Bioequivalence Study of Pseudoephedrine HCl 120 mg ER Tablets Under Fed Conditions
Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
The objective of the study was to compare the single dose oral bioavailability of
Pseudoephedrine hydrochloride 120 mg ER tablets of Ranbaxy with Sudafed 120 mg ER tablets of
Pfizer Consumer Health Care in healthy, adult, human subjects under fed conditions.